Comparison of immunoperoxidase staining of 3 different types of CD5 antibodies in a spectrum of breast lesions

Archives of Pathology and Laboratory Medicine

Volumn 125, Issue 6, 2001, Pages 781-784

  Walsh, R ^a   Peston, D ^a   Shousha, S ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; BIOTIN; LYMPHOCYTE ANTIBODY; PARAFFIN; PEROXIDASE;

ARTICLE; BREAST BIOPSY; BREAST DISEASE; CANCER GRADING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; TISSUE SECTION;

ANTIBODIES; ANTIGENS, CD5; BREAST; BREAST DISEASES; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; STAINING AND LABELING;

EID: 0034993584     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. CD5 positive breast carcinoma in a patient with untreated chronic lymphocytic leukaemia: Molecular studies of chromosome 13Q
2. Studies of a human T lymphocyte antigen recognized by a monoclonal antibody
3. Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1
4. Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: Molecular homology to its human counterpart Leu-1/T1 (CD5)
5. Chronic lymphocytic leukemia: An updated review
6. - lymphocytes
7. Mantle cell lymphoma: An entity comes of age
8. CD5+ extranodal marginal zone B-cell (MALT) lymphoma: A low grade neoplasm with a propensity for bone marrow involvement and relapse
9. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity
10. Intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) exhibits CD5 immunoreactivity: New evidence for thymic differentiation
11. CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms